LPL Financial’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,660
| Closed | -$226K | – | 3222 |
|
|
2019
Q4 | $226K | Buy |
+3,660
| New | +$226K | ﹤0.01% | 2986 |
|
|
2017
Q4 | – | Sell |
-3,550
| Closed | -$217K | – | 3007 |
|
|
2017
Q3 | $217K | Sell |
3,550
-455
| -11% | -$27.8K | ﹤0.01% | 2594 |
|
|
2017
Q2 | $214K | Sell |
4,005
-295
| -7% | -$15.8K | ﹤0.01% | 2529 |
|
|
2017
Q1 | $204K | Sell |
4,300
-6,358
| -60% | -$302K | ﹤0.01% | 2477 |
|
|
2016
Q4 | $441K | Sell |
10,658
-1,931
| -15% | -$79.9K | ﹤0.01% | 1841 |
|
|
2016
Q3 | $605K | Sell |
12,589
-1,631
| -11% | -$78.4K | 0.01% | 1553 |
|
|
2016
Q2 | $590K | Sell |
14,220
-18,990
| -57% | -$788K | 0.01% | 1533 |
|
|
2016
Q1 | $1.45M | Sell |
33,210
-4,520
| -12% | -$198K | ﹤0.01% | 1393 |
|
|
2015
Q4 | $2.51M | Buy |
37,730
+19,182
| +103% | +$1.28M | 0.01% | 1030 |
|
|
2015
Q3 | $1.16M | Buy |
18,548
+657
| +4% | +$41.1K | 0.01% | 1150 |
|
|
2015
Q2 | $1.64M | Sell |
17,891
-2,221
| -11% | -$204K | 0.01% | 1025 |
|
|
2015
Q1 | $1.56M | Buy |
20,112
+1,090
| +6% | +$84.7K | 0.01% | 1052 |
|
|
2014
Q4 | $1.19M | Buy |
19,022
+2,874
| +18% | +$180K | 0.01% | 1188 |
|
|
2014
Q3 | $814K | Sell |
16,148
-5,826
| -27% | -$294K | ﹤0.01% | 1412 |
|
|
2014
Q2 | $1.02M | Sell |
21,974
-18,230
| -45% | -$846K | 0.01% | 1305 |
|
|
2014
Q1 | $1.61M | Buy |
40,204
+7,524
| +23% | +$300K | 0.01% | 953 |
|
|
2013
Q4 | $1.23M | Sell |
32,680
-26,508
| -45% | -$998K | 0.01% | 1107 |
|
|
2013
Q3 | $1.8M | Buy |
59,188
+22,320
| +61% | +$678K | 0.01% | 844 |
|
|
2013
Q2 | $836K | Buy |
+36,868
| New | +$836K | 0.01% | 1230 |
|